Innova Wealth Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.09M Buy
1,744
+288
+20% +$294K 0.86% 31
2026
Q1
$1.34M Sell
1,456
-16
-1% -$16.2K 0.63% 35
2025
Q4
$1.58M Buy
1,472
+212
+17% +$203K 0.8% 37
2025
Q3
$961K Buy
1,260
+162
+15% +$121K 0.52% 40
2025
Q2
$856K Buy
1,098
+34
+3% +$26.4K 0.5% 38
2025
Q1
$879K Buy
1,064
+1
+0.1% +$832 0.54% 33
2024
Q4
$821K Buy
+1,063
New +$880K 0.52% 36
2024
Q3
Sell
-1,068
Closed -$967K 109
2024
Q2
$967K Hold
1,068
0.69% 35
2024
Q1
$831K Buy
1,068
+13
+1% +$9.25K 0.64% 33
2023
Q4
$615K Hold
1,055
0.53% 30
2023
Q3
$567K Hold
1,055
0.51% 28
2023
Q2
$495K Sell
1,055
-345
-25% -$145K 0.42% 33
2023
Q1
$481K Hold
1,400
0.42% 28
2022
Q4
$512K Hold
1,400
0.45% 31
2022
Q3
$453K Hold
1,400
0.41% 26
2022
Q2
$454K Hold
1,400
0.38% 26
2022
Q1
$401K Hold
1,400
0.29% 39
2021
Q4
$387K Sell
1,400
-160
-10% -$40.6K 0.27% 42
2021
Q3
$360K Sell
1,560
-349
-18% -$86.1K 0.29% 47
2021
Q2
$438K Sell
1,909
-575
-23% -$116K 0.35% 42
2021
Q1
$464K Buy
2,484
+60
+2% +$11.7K 0.39% 37
2020
Q4
$409K Buy
+2,424
New +$362K 0.38% 40

Other funds holding LLY

Innova Wealth Partners's LLY Position: Q2 2026 in Review

Innova Wealth Partners increased its Eli Lilly (LLY) stake by 20% in Q2 2026, buying an estimated $294K and bringing the position to 1,744 shares worth $2.09M. The position accounts for 0.86% of the portfolio, ranked #31.

Innova Wealth Partners first reported a position in LLY in Q4 2020 and has held it in 22 quarters since. 1,842 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Innova Wealth Partners held 1,744 shares of Eli Lilly worth $2.09M as of Q2 2026.
  • Innova Wealth Partners bought 288 Eli Lilly shares in Q2 2026, an estimated $294K.
  • Eli Lilly made up 0.86% of Innova Wealth Partners's portfolio in Q2 2026, its #31 holding.
  • Innova Wealth Partners first reported a position in Eli Lilly in Q4 2020 and has held it in 22 quarters since.
  • 1,842 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Innova Wealth Partners's 13F filing for Q2 2026, filed 15 Jul 2026.